Eagle Pharmaceuticals
EGRX
$4.75
Share price
3.94%
Change (1 day)
-83.72%
Change (1 year)
Categories
Eagle Pharmaceuticals (EGRX) - Total assets
Total assets on the balance sheet as of June 2023 : $0.40 B
According to Eagle Pharmaceuticals 's latest financial reports the company's total assets are $0.40 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Eagle Pharmaceuticals - Total assets on balance sheet (from 2013 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.40 B | 60.07% |
| 2021-12-31 | $0.25 B | 0.21% |
| 2020-12-31 | $0.25 B | -0.54% |
| 2019-12-31 | $0.25 B | 6.69% |
| 2018-12-31 | $0.23 B | -11.65% |
| 2017-12-31 | $0.27 B | 26.01% |
| 2016-12-31 | $0.21 B | 72% |
| 2015-12-31 | $0.12 B | |
| 2014-09-30 | $53.41 M | 195.04% |
| 2013-09-30 | $18.1 M | 91.81% |
| 2012-09-30 | $9.43 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $171.96 B | 42,379.41% | 🇺🇸 USA |
 Novartis NVS | $94.33 B | 23,202.59% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $63.94 B | 15,695.46% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 23,899.19% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 24,362.85% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $73.94 B | 18,165.29% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $43.47 B | 10,640.28% | 🇮🇱 Israel |